Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

SEP 8, 2026 · JOURNAL ARTICLE

Case Report: Invasive mucinous adenocarcinoma mimicking interstitial pneumonia with autoimmune features: diagnostic pitfalls and reflections

Frontiers in Immunology

A single case report describing diagnostic misidentification of lung cancer as autoimmune interstitial pneumonia; raises awareness of a pitfall but provides no comparative data or outcome measures to support clinical decision-making.

SEP 4, 2026 · JOURNAL ARTICLE

Real-World Treatment Patterns and Clinical Outcomes After First-Line Therapy in Patients with KRAS G12C-Mutant Advanced Non-Small-Cell Lung Cancer in the United States

Cancers

Retrospective real-world observational study without randomisation or concurrent control arms; provides outcome descriptors and treatment patterns but cannot establish comparative efficacy or causality for treatment strategies.

AUG 12, 2026 · JOURNAL ARTICLE

Hypothesis-driven salvage therapy with corticosteroids, tofacitinib, and nintedanib for progressive radiation pneumonitis with possible immune-mediated contribution: a case report

Frontiers in Immunology

A single case report with clinical improvement and biomarker response, but no control group, no prospective design, and no evidence of safety or efficacy beyond one patient.

AUG 11, 2026 · JOURNAL ARTICLE

Human Metapneumovirus as an Emerging Respiratory Pathogen: A Comprehensive Review

Journal of Monno Medical College

A comprehensive narrative review synthesizing current knowledge of hMPV epidemiology, clinical features, and management gaps; informs clinicians on disease recognition and the absence of specific therapies.

AUG 5, 2026 · JOURNAL ARTICLE

Human Embryonic Stem Cell‐Derived Immunity‐And‐Matrix‐Regulatory Cells Attenuate Pulmonary Fibrosis via MMP1 ‐Mediated Collagen Degradation

Cell Proliferation

Mechanistic study using gene-edited cells and animal models to establish MMP1 as a biomarker, but lacks human efficacy data and represents exploratory preclinical work rather than a clinical trial or definitive evidence.

JUN 29, 2026 · JOURNAL ARTICLE

Galectin-3 as a marker of arrhythmia in childrenand adolescents: are we on the right track?

Diagnostyka Laboratoryjna

This is a narrative review concluding that Gal-3's role in pediatric arrhythmia diagnosis remains inconclusive, with inconsistent data and small study groups preventing clinical recommendation.